PUBLICATIONS · 30957229
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Haematol
- Publication date
- 2019 Jul
- First author
- Horton TM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Horton TM
- type
- Author
- name
- Whitlock JA
- type
- Author
- name
- Lu X
- type
- Author
- name
- O'Brien MM
- type
- Author
- name
- Borowitz MJ
- type
- Author
- name
- Devidas M
- type
- Author
- name
- Raetz EA
- type
- Author
- name
- Brown PA
- type
- Author
- name
- Carroll WL
- type
- Author
- name
- Hunger SP
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Horton TM
- type
- Author
- name
- Whitlock JA
- type
- Author
- name
- Lu X
- type
- Author
- name
- O'Brien MM
- type
- Author
- name
- Borowitz MJ
- type
- Author
- name
- Devidas M
- type
- Author
- name
- Raetz EA
- type
- Author
- name
- Brown PA
- type
- Author
- name
- Carroll WL
- type
- Author
- name
- Hunger SP
- type
- Author
- bibliography ids
- nci-bib-50cd482d8214b82f0cd7f36f
- book metadata
- content sha256
- 0d3ae1037ed5585a6256313b479eb44f1c1fea588d9e3055b5636987a22198bf
- document type
- citation
- dois
- 10.1111/bjh.15919
- electronic publication date
- display
- 2019 Apr 7
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30957229
- immutable id
- pubmed:30957229@0d3ae1037ed5585a6256313b479eb44f1c1fea588d9e3055b5636987a22198bf
- journal
- abbreviation
- Br J Haematol
- issn electronic
- 1365-2141
- issn print
- 0007-1048
- issue
- 2
- name
- British journal of haematology
- nlm unique id
- 0372544
- pages
- 274-285
- volume
- 186
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30957229
- provenance
- batch id
- e808962322f3afebc564
- provider
- NCBI PubMed ESummary
- record sha256
- 5da188800404855696e8c067850d17935cd67f12b160dfaf32635c332297041c
- response sha256
- 3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
- retrieved at
- 2026-09-09T23:47:41.002093+00:00
- publication date
- display
- 2019 Jul
- precision
- month
- year
- 2019
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Preserved source evidence · Not medical advice
Triangle